Fulton appoints new management team
Restructures Bristol-based business
Following the retirement of the UK firm’s sales and marketing and technical directors, Fulton Inc has restructured the business and appointed Paul Richards as managing director and Carl Knight as UK and European sales and marketing manager.
Richards previously worked for Solatron, while Knight joins Fulton from Spirax Sarco.
Richards said: ‘The changes haven’t just stopped with management appointments. We have also restructured and changed the trading name from Fulton Boiler Works (GB) to Fulton, as we feel it better reflects the business and markets we now operate in.’
Once just a steam boiler manufacturer, Fulton now specialises in the design and manufacture of energy efficient products and ready-to-ship skid mounted and fully packaged boiler plant rooms, he added.
‘We put great emphasis on providing sales and application advice and a full commissioning and after sales service to a growing customer base in hospital and healthcare facilities, food and beverage processing, laundries and other applications.’
Fulton recently introduced of a VMP vertical tubeless boiler, ModSync boiler sequencing system and TDS energy recovery system.
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model
Manufacturing
BioNTech to cut up to 1860 jobs and end COVID vaccine production in Germany
The German biotech has announced it will cease production at its manufacturing sites in Germany and Singapore in its Q1 earnings report, cutting up to 22% of its workforce in the process as it pivots from COVID-19 vaccines to oncology